0001182489-18-000381.txt : 20180905
0001182489-18-000381.hdr.sgml : 20180905
20180905182733
ACCESSION NUMBER: 0001182489-18-000381
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180831
FILED AS OF DATE: 20180905
DATE AS OF CHANGE: 20180905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MEANWELL CLIVE
CENTRAL INDEX KEY: 0001204787
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31191
FILM NUMBER: 181056299
MAIL ADDRESS:
STREET 1: THE MEDICINES CO
STREET 2: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDICINES CO /DE
CENTRAL INDEX KEY: 0001113481
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043324394
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-290-6000
MAIL ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: MEDICINES CO/ MA
DATE OF NAME CHANGE: 20000504
4
1
edgar.xml
FORM 4 -
X0306
4
2018-08-31
0
0001113481
MEDICINES CO /DE
MDCO
0001204787
MEANWELL CLIVE
8 SYLVAN WAY
PARSIPPANY
NJ
07054
1
1
0
0
CEO
Common Stock
2018-08-31
4
A
0
375
28.28
A
352409
D
Common Stock
2018-09-04
4
S
0
50000
39.31
D
302409
D
Shares of common stock acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning March 1, 2018 and ending August 31, 2018. In accordance with the terms of the ESPP, these share were purchased based on 85% of the fair market value closing price of the issuer's common stock on March 1, 2018.
Sales were effected pursuant to a Rule 10b5-1 program adopted by Dr. Meanwell. Dr. Meanwell's 10b5-1 program is terminated.
Represents the weighted average sales price of the shares sold ranging from a low of $39.03 to a high of $39.77 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
/s/ Stephen M. Rodin, Attorney-in-Fact for Clive Meanwell
2018-09-05